182 related articles for article (PubMed ID: 20511614)
1. Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?
Holle JU; Gross WL; Holl-Ulrich K; Ambrosch P; Noelle B; Both M; Csernok E; Moosig F; Schinke S; Reinhold-Keller E
Ann Rheum Dis; 2010 Nov; 69(11):1934-9. PubMed ID: 20511614
[TBL] [Abstract][Full Text] [Related]
2. [Wegener granulomatosis and microscopic polyangiitis. Diagnostic and clinical results in 54 patients with long-term follow-up].
Bolley R; Mistry-Burchardi N; Samtleben W
Dtsch Med Wochenschr; 2000 Dec; 125(50):1519-25. PubMed ID: 11190761
[TBL] [Abstract][Full Text] [Related]
3. Predictors of damage and survival in patients with Wegener's granulomatosis: analysis of 50 patients.
Kamali S; Erer B; Artim-Esen B; Gul A; Ocal L; Konice M; Aral O; Inanc M
J Rheumatol; 2010 Feb; 37(2):374-8. PubMed ID: 20008921
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis.
Lurati-Ruiz F; Spertini F
J Rheumatol; 2005 Nov; 32(11):2167-72. PubMed ID: 16265696
[TBL] [Abstract][Full Text] [Related]
5. Lessons learnt in the management of Wegener's Granulomatosis: long-term follow-up of 60 patients.
Sproson EL; Jones NS; Al-Deiri M; Lanyon P
Rhinology; 2007 Mar; 45(1):63-7. PubMed ID: 17432073
[TBL] [Abstract][Full Text] [Related]
6. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.
Martinez V; Cohen P; Pagnoux C; Vinzio S; Mahr A; Mouthon L; Sailler L; Delaunay C; Sadoun A; Guillevin L;
Arthritis Rheum; 2008 Jan; 58(1):308-17. PubMed ID: 18163506
[TBL] [Abstract][Full Text] [Related]
8. Wegener's granulomatosis--clinical analysis of 18 patients group.
Dabrowski A; Droszcz W
Med Sci Monit; 2000; 6(1):151-7. PubMed ID: 11208304
[TBL] [Abstract][Full Text] [Related]
9. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.
Martinez Del Pero M; Chaudhry A; Jones RB; Sivasothy P; Jani P; Jayne D
Clin Otolaryngol; 2009 Aug; 34(4):328-35. PubMed ID: 19673980
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous manifestations of Wegener's granulomatosis: a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status.
Comfere NI; Macaron NC; Gibson LE
J Cutan Pathol; 2007 Oct; 34(10):739-47. PubMed ID: 17880578
[TBL] [Abstract][Full Text] [Related]
11. Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations.
Holle JU; Dubrau C; Herlyn K; Heller M; Ambrosch P; Noelle B; Reinhold-Keller E; Gross WL
Ann Rheum Dis; 2012 Mar; 71(3):327-33. PubMed ID: 22021864
[TBL] [Abstract][Full Text] [Related]
12. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.
Boomsma MM; Stegeman CA; van der Leij MJ; Oost W; Hermans J; Kallenberg CG; Limburg PC; Tervaert JW
Arthritis Rheum; 2000 Sep; 43(9):2025-33. PubMed ID: 11014352
[TBL] [Abstract][Full Text] [Related]
13. Orbital masses in granulomatosis with polyangiitis are associated with a refractory course and a high burden of local damage.
Holle JU; Voigt C; Both M; Holl-Ulrich K; Nölle B; Laudien M; Moosig F; Gross WL
Rheumatology (Oxford); 2013 May; 52(5):875-82. PubMed ID: 23293138
[TBL] [Abstract][Full Text] [Related]
14. Antineutrophil cytoplasmic autoantibody in the absence of Wegener's granulomatosis or microscopic polyangiitis: implications for the surgical pathologist.
Gal AA; Velasquez A
Mod Pathol; 2002 Mar; 15(3):197-204. PubMed ID: 11904336
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and outcome of pediatric Wegener's granulomatosis.
Akikusa JD; Schneider R; Harvey EA; Hebert D; Thorner PS; Laxer RM; Silverman ED
Arthritis Rheum; 2007 Jun; 57(5):837-44. PubMed ID: 17530684
[TBL] [Abstract][Full Text] [Related]
16. Wegener's granulomatosis: a challenging disease for otorhinolaryngologists.
Cadoni G; Prelajade D; Campobasso E; Calŏ L; Agostino S; Manna R; Paludetti G
Acta Otolaryngol; 2005 Oct; 125(10):1105-10. PubMed ID: 16298794
[TBL] [Abstract][Full Text] [Related]
17. [Wegener's granulomatosis in 2 adolescents].
van der Aa LB; van der Heide M; Sprikkelman AB; Brinkhorst G; Tytgat GA; van den Berg JM
Ned Tijdschr Geneeskd; 2007 Jul; 151(27):1522-6. PubMed ID: 17763812
[TBL] [Abstract][Full Text] [Related]
18. [Detection of antineutrophil cytoplasmic antibodies for the values of Wegener's granulomatosis diagnosis and activity judgment].
Zhang X; Jiang M; Chui J; Wang H; Ma J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):284-7. PubMed ID: 10453568
[TBL] [Abstract][Full Text] [Related]
19. [Wegener's granulomatosis: otologic and clinico-immunologic aspects].
Kempf HG; Bootz F; Berg PA
Laryngorhinootologie; 1992 Jan; 71(1):26-30. PubMed ID: 1543518
[TBL] [Abstract][Full Text] [Related]
20. Difficulty of diagnosing Wegener's granulomatosis in the head and neck region.
Tsuzuki K; Fukazawa K; Takebayashi H; Hashimoto K; Sakagami M
Auris Nasus Larynx; 2009 Feb; 36(1):64-70. PubMed ID: 18479857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
